Article
Developing neuroprotective drugs for glaucoma no easy task
Neuroprotection is a concept that originated in the CNS community with the development of therapies aimed at preventing or retarding the manifestations of disorders such as Parkinson's and Alzheimer's diseases, stroke, and head trauma. Less than 15 years ago, the ophthalmic community began to discuss this concept as a novel way to preserve vision in disorders of the retina.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
